Valuation: RAMM Pharma Corp.

Market Cap 1.19M 860K 743K 698K 635K 82.27M 1.21M 8.18M 3.2M 41.2M 3.23M 3.16M 137M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 339K 293K 275K 250K 32.41M 478K 3.22M 1.26M 16.23M 1.27M 1.25M 53.94M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 month+100.00%
3 months-33.33%
6 months-60.00%
Current year-83.33%
1 week 0.01
Extreme 0.01
0.01
1 month 0.01
Extreme 0.01
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.75
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 2019-09-30
Director of Finance/CFO - 2022-12-08
Director TitleAgeSince
Director/Board Member - 2019-09-30
Director/Board Member 82 2019-09-30
Director/Board Member 66 2019-09-30
Date Insider Type Main position Quantity % Market Cap.
6/2/25 Sell

Chief Executive Officer

4,667,000 3.9091%
3/21/25 Buy

Chief Executive Officer

200,000 0.1675%
3/21/25 Buy

Chief Executive Officer

100,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-80.00% 860K
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -1.03%+0.39%+24.44%+30.40% 359.52B
Weighted average by Cap. -1.36%+0.32%+39.09%+61.29%

Financials

2024 2025
Net sales 4.34M 3.13M 2.7M 2.54M 2.31M 299M 4.41M 29.75M 11.63M 150M 11.75M 11.49M 498M 3.36M 2.42M 2.09M 1.97M 1.79M 232M 3.42M 23.03M 9M 116M 9.09M 8.89M 385M
Net income -16.5M -11.89M -10.27M -9.65M -8.78M -1.14B -16.77M -113M -44.22M -569M -44.65M -43.68M -1.89B -8.91M -6.42M -5.55M -5.21M -4.74M -614M -9.06M -61.06M -23.87M -307M -24.11M -23.58M -1.02B
Net Debt -626K -451K -389K -366K -333K -43.12M -636K -4.29M -1.68M -21.59M -1.69M -1.66M -71.75M -723K -521K -450K -423K -385K -49.85M -735K -4.96M -1.94M -24.96M -1.96M -1.91M -82.96M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
26-08-12 $0.0100 0.00% 100,000
  1. Stock Market
  2. Stocks
  3. RAMM Stock